- Conditions
- Primary Aldosteronism, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
- Interventions
- Amlodipine
- Drug
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Apr 14, 2025 · Synced May 21, 2026, 6:23 PM EDT